{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Use of myostatin inhibitors and combination therapies", "item": "https://www.patentleaderboard.com/patent/10946036"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of myostatin inhibitors and combination therapies

Use of myostatin inhibitors and combination therapies

US Patent 10946036 · Granted Mar 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biochemical probes attached to epoxy-based resins2025
Compositions and methods for growth factor modulation2025
Plasma kallikrein binding proteins and uses thereof in treating hereditary angio2025
RGMC-selective inhibitors and use thereof2025
Methods for altering body composition by administering anti-pro/latent myostatin2024
Methods for altering body composition by administering anti-pro/latent myostatin2024
Compositions for making and using anti-Myostatin antibodies2024
Compositions and methods for growth factor modulation2023
TGFβ1-binding immunoglobulins and use thereof2023
Methods for using anti-myostatin antibodies2022
Methods for using anti-myostatin antibodies2022
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema2022